Suppr超能文献

使基于发夹结构的RNA干扰载体中的变量最小化,揭示了短发夹RNA的效能。

Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs.

作者信息

Boudreau Ryan L, Monteys Alex Mas, Davidson Beverly L

机构信息

Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA.

出版信息

RNA. 2008 Sep;14(9):1834-44. doi: 10.1261/rna.1062908. Epub 2008 Aug 12.

Abstract

RNA interference (RNAi) is a cellular process regulating gene expression and participating in innate defense in many organisms. RNAi has also been utilized as a tool to query gene function and is being developed as a therapeutic strategy for several diseases. Synthetic small interfering (siRNAs) or expressed stem-loop RNAs (short-hairpin RNAs [shRNAs] or artificial microRNAs [miRNAs]) have been delivered to cultured cells and organisms to inhibit expression of a variety of genes. A persistent question in the field, however, is which RNAi expression system is most suitable for distinct applications. To date, shRNA- and artificial miRNA-based strategies have been compared with conflicting results. In prior comparisons, sequences required for efficient RNAi processing and loading of the intended antisense strand into the RNAi-induced silencing complex (RISC) were not considered. We therefore revisited the shRNA-miRNA comparison question. Initially, we developed an improved artificial miRNA vector and confirmed the optimal shRNA configuration by altering structural features of these RNAi substrates. Subsequently, we engineered and compared shRNA- and miRNA-based RNAi expression vectors that would be processed to yield similar siRNAs that exhibit comparable strand biasing. Our results demonstrate that when comparison variables are minimized, the shRNAs tested were more potent than the artificial miRNAs in mediating gene silencing independent of target sequence and experimental setting (in vitro and in vivo). In addition, we show that shRNAs are expressed at considerably higher levels relative to artificial miRNAs, thus providing mechanistic insight to explain their increased potency.

摘要

RNA干扰(RNAi)是一种细胞过程,可调节基因表达并参与许多生物体的天然防御。RNAi也已被用作查询基因功能的工具,并正在开发成为多种疾病的治疗策略。合成的小干扰RNA(siRNA)或表达的茎环RNA(短发夹RNA [shRNA]或人工微小RNA [miRNA])已被递送至培养的细胞和生物体中,以抑制多种基因的表达。然而,该领域一直存在的一个问题是,哪种RNAi表达系统最适合不同的应用。迄今为止,基于shRNA和人工miRNA的策略已经进行了比较,但结果相互矛盾。在先前的比较中,未考虑有效RNAi加工以及将预期的反义链加载到RNA干扰诱导沉默复合体(RISC)中所需的序列。因此,我们重新审视了shRNA与miRNA的比较问题。首先,我们开发了一种改进的人工miRNA载体,并通过改变这些RNAi底物的结构特征来确认最佳的shRNA构型。随后,我们构建并比较了基于shRNA和miRNA的RNAi表达载体,这些载体经过加工后会产生相似的siRNA,它们表现出可比的链偏向性。我们的结果表明,当比较变量最小化时,所测试的shRNA在介导基因沉默方面比人工miRNA更有效,且与靶序列和实验设置(体外和体内)无关。此外,我们表明,相对于人工miRNA,shRNA的表达水平要高得多,从而为解释它们增强的效力提供了机制上的见解。

相似文献

3
Artificial miRNAs as therapeutic tools: Challenges and opportunities.人工 miRNA 作为治疗工具:挑战与机遇。
Wiley Interdiscip Rev RNA. 2021 Jul;12(4):e1640. doi: 10.1002/wrna.1640. Epub 2021 Jan 1.

引用本文的文献

3
Current trends in gene therapy to treat inherited disorders of the brain.治疗遗传性脑部疾病的基因治疗当前趋势。
Mol Ther. 2025 May 7;33(5):1988-2014. doi: 10.1016/j.ymthe.2025.03.057. Epub 2025 Apr 2.
4
Engineering strategies to safely drive CAR T-cells into the future.工程化策略助力 CAR T 细胞安全迈入未来。
Front Immunol. 2024 Jun 19;15:1411393. doi: 10.3389/fimmu.2024.1411393. eCollection 2024.
6
NADPH Oxidase 3: Beyond the Inner Ear.NADPH氧化酶3:内耳之外
Antioxidants (Basel). 2024 Feb 8;13(2):219. doi: 10.3390/antiox13020219.
9
Gene Therapy for Rhodopsin Mutations.视紫红质突变的基因治疗
Cold Spring Harb Perspect Med. 2022 Aug 8;12(9). doi: 10.1101/cshperspect.a041283.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验